| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 7.38 | 0.00 (0.00%) | 1.15 - 7.50 | 0.0 |
Market data as of 4:00PM 05/22/13. Quotes are delayed by at least 15 min.
| Open | -- |
|---|---|
| Previous Close | 7.38 |
| Day's Range | -- - -- |
| Market Cap | 708.1M |
| Avg Volume (10 Day) | 524.1K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.1 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
MiMedx to Present at The 10th Annual Craig-Hallum Institutional Investor Conference
PR Newswire - Wednesday 05/22/2013 11:28 AM ET
MiMedx Secures a $3.0 Million Revolving Line of Credit with Bank of America
PR Newswire - Monday 05/20/2013 2:58 PM ET
MiMedx Announces Record First Quarter 2013 Results
PR Newswire - Wednesday 05/01/2013 7:00 AM ET
MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
PR Newswire - Monday 04/22/2013 2:38 PM ET
| MDXG | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 234.89% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.00 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | -- | |
| Price/Sales | 19.60 |
| Company | Last | Change |
|---|---|---|
| Greatbatch Inc | 31.84 | 0.00% |
| Nxstage Medical Inc | 13.74 | 0.00% |
| Spectranetics Corp | 18.92 | 0.00% |
| MAKO Surgical Corp | 11.00 | 0.00% |
| Orthofix International NV | 26.55 | 0.00% |
Data is delayed by at least 15 min.